Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015 Academic Article uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • This initiative was undertaken in response to concerns regarding the variation in management and in outcomes of patients with bladder cancer throughout centres and geographical areas in Canada. Population-based data have also revealed that real-life survival is lower than expected based on data from clinical trials and/or academic centres. To address these perceived shortcomings and attempt to streamline and unify treatment approaches to bladder cancer in Canada, a multidisciplinary panel of expert clinicians was convened last fall for a two-day working group consensus meeting. The panelists included urologic oncologists, medical oncologists, radiation oncologists, patient representatives, a genitourinary pathologist, and an enterostomal therapy nurse. The following recommendations and summaries of supporting evidence represent the results of the presentations, debates, and discussions. Methodology

authors

  • Kassouf, Wassim
  • Aprikian, Armen
  • Black, Peter
  • Kulkarni, Girish
  • Izawa, Jonathan
  • Eapen, Libni
  • Fairey, Adrian
  • So, Alan
  • North, Scott
  • Rendon, Ricardo
  • Sridhar, Srikala S
  • Alam, Tarik
  • Brimo, Fadi
  • Blais, Normand
  • Booth, Chris
  • Chin, Joseph
  • Chung, Peter
  • Drachenberg, Darrel
  • Fradet, Yves
  • Jewett, Michael
  • Moore, Ron
  • Morash, Chris
  • Shayegan, Bobby
  • Gotto, Geoffrey
  • Fleshner, Neil
  • Saad, Fred
  • Siemens, D Robert

publication date

  • January 2016